GE HealthCare Technologies
Open
$60.03
Prev. Close
$60.00
High
$60.09
Low
$59.99
Market Snapshot
$27.11B
14.2
4.76
$19.8B
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE HealthCare Technologies reported Q1 financial results, achieving 10.1% margins, with $5.7 billion in revenue and $589 million net income during its earnings call.
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Recently from Cashu
GE HealthCare Technologies: Leading Innovative AI Solutions in Evolving Healthcare Landscape
GE HealthCare Technologies: Innovating Healthcare Solutions Amid Industry Changes In the dynamic landscape of healthcare technology, GE HealthCare Technologies stands at the forefront of innovation, p…
GE HealthCare Technologies Receives Buy Upgrade Amid Promising Growth Trends and Innovations
GE HealthCare Technologies Eyes Growth Amid Upgrades and Stabilizing Trends In recent developments, GE HealthCare Technologies stands out in the healthcare sector as Goldman Sachs upgrades its rating…
GE HealthCare Technologies Gains Momentum with Goldman Sachs Upgrade Amid Market Changes
GE HealthCare Technologies Sees Positive Momentum Amid Market Shifts In a notable development for the healthcare technology sector, GE HealthCare Technologies experiences a boost in investor confidenc…
GE HealthCare Technologies Achieves Strong Growth Driven by Innovation and Operational Excellence
GE HealthCare's Robust Performance Reflects Strategic Focus on Innovation GE HealthCare Technologies showcases a strong financial performance for the fourth quarter and the full year ending December 3…